A policy analysis of how alkyl nitrites (poppers) became prescription-only in Aotearoa New Zealand.

As a drug policy case study, it appears that reclassification was initiated due to a policy process that did not enable or support plausible alternatives. While the purpose of the reclassification was to improve safety, there was no evidence of harm prior to reclassification, and the reduction in access is likely to have increased harm for MSM.